Goodrx Holdings Financials
| GDRX Stock | USD 4.74 0.05 1.04% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.22 | 5.3207 |
|
|
The financial analysis of Goodrx Holdings is a critical element in measuring its lifeblood. Investors should not minimize Goodrx Holdings' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Goodrx | Select Account or Indicator |
Understanding current and past Goodrx Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Goodrx Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in Goodrx Holdings' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Goodrx Holdings' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Goodrx Holdings. Check Goodrx Holdings' Beneish M Score to see the likelihood of Goodrx Holdings' management manipulating its earnings.
Goodrx Holdings Stock Summary
Goodrx Holdings competes with Teladoc, Talkspace, Accolade, Doximity, and Veeva Systems. GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company was incorporated in 2015 and is headquartered in Santa Monica, California. GoodRx Holdings operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 756 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US38246G1085 |
| CUSIP | 38246G108 |
| Location | California; U.S.A |
| Business Address | 2701 Olympic Boulevard, |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.goodrx.com |
| Phone | 855 268 2822 |
| Currency | USD - US Dollar |
Goodrx Holdings Key Financial Ratios
| Return On Equity | 0.022 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.19 % | ||||
| Price To Sales | 2.32 X | ||||
| Revenue | 792.32 M |
Goodrx Holdings Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 1.5B | 1.6B | 1.6B | 1.6B | 1.4B | 1.3B | |
| Other Current Liab | 26.3M | 38.0M | 35.6M | 64.2M | 97.7M | 102.6M | |
| Other Liab | 3.0M | 5.8M | 5.4M | 7.6M | 8.7M | 6.3M | |
| Net Tangible Assets | (1.4B) | 393.5M | 831.7M | 814.8M | 937.1M | 983.9M | |
| Net Debt | (263.8M) | (238.8M) | (40.1M) | 38.8M | (391.7M) | (372.1M) | |
| Retained Earnings | (1.4B) | (1.4B) | (1.4B) | (1.5B) | (1.4B) | (1.5B) | |
| Accounts Payable | 10.3M | 17.5M | 17.7M | 36.3M | 14.1M | 17.4M | |
| Cash | 968.7M | 941.1M | 757.2M | 672.3M | 448.3M | 604.7M | |
| Other Assets | 3.4M | 15.1M | 6.0M | 8.2M | 9.4M | 7.6M | |
| Long Term Debt | 659.9M | 655.9M | 651.8M | 647.7M | 486.7M | 512.3M | |
| Net Receivables | 68.7M | 126.4M | 117.1M | 160.0M | 160.8M | 113.7M | |
| Good Will | 261.1M | 329.7M | 412.1M | 410.8M | 472.4M | 358.5M | |
| Other Current Assets | 48.9M | 21.3M | 16.0M | 40.4M | 50.1M | 30.3M | |
| Total Liab | 758.8M | 775.9M | 789.8M | 826.8M | 663.4M | 773.3M | |
| Net Invested Capital | 1.4B | 1.5B | 1.5B | 1.4B | 1.2B | 962.4M | |
| Total Current Assets | 1.1B | 1.1B | 919.7M | 872.8M | 659.3M | 752.2M | |
| Net Working Capital | 1.0B | 1.0B | 843.4M | 750.2M | 535.4M | 671.5M | |
| Short Term Debt | 16.1M | 18.7M | 15.2M | 15.0M | 10.6M | 14.3M | |
| Intangible Assets | 56.7M | 133.8M | 189.9M | 156.3M | 52.1M | 99.6M |
Goodrx Holdings Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | (9.8M) | 15.1M | 9.6M | (50.7M) | 15.1M | 15.8M | |
| Net Interest Income | (27.8M) | (23.6M) | (25.0M) | (24.7M) | (29.6M) | (31.1M) | |
| Interest Income | 160K | 59K | 9.3M | 29.1M | 23.3M | 24.4M | |
| Interest Expense | 27.9M | 23.6M | 34.2M | 56.7M | 52.9M | 42.0M | |
| Total Revenue | 550.7M | 745.4M | 766.6M | 750.3M | 792.3M | 666.8M | |
| Gross Profit | 521.1M | 698.7M | 701.5M | 683.3M | 744.1M | 623.3M | |
| Operating Income | (275.7M) | 13.4M | 11.0M | (27.0M) | 65.8M | 69.1M | |
| Ebit | (280.0M) | 10.4M | 11.0M | 1.2M | 84.4M | 88.6M | |
| Research Development | 61.8M | 125.9M | 143.1M | 135.8M | 123.7M | 104.3M | |
| Ebitda | (257.1M) | 48.0M | 68.5M | 108.8M | 153.9M | 161.6M | |
| Cost Of Revenue | 29.6M | 46.7M | 65.1M | 66.9M | 48.2M | 43.5M | |
| Income Before Tax | (303.5M) | (10.2M) | (23.2M) | (55.6M) | 31.5M | 33.0M | |
| Net Income | (293.6M) | (25.3M) | (32.8M) | (8.9M) | 16.4M | 17.2M | |
| Income Tax Expense | (9.8M) | 15.1M | 9.6M | (46.7M) | 15.1M | 15.8M |
Goodrx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Goodrx Holdings's current stock value. Our valuation model uses many indicators to compare Goodrx Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Goodrx Holdings competition to find correlations between indicators driving Goodrx Holdings's intrinsic value. More Info.Goodrx Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 1.65 of Return On Asset per Return On Equity. At this time, Goodrx Holdings' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Goodrx Holdings' earnings, one of the primary drivers of an investment's value.Goodrx Holdings Systematic Risk
Goodrx Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Goodrx Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Goodrx Holdings correlated with the market. If Beta is less than 0 Goodrx Holdings generally moves in the opposite direction as compared to the market. If Goodrx Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Goodrx Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Goodrx Holdings is generally in the same direction as the market. If Beta > 1 Goodrx Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Goodrx Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Goodrx Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Goodrx Holdings growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Goodrx Holdings March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Goodrx Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Goodrx Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Goodrx Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Goodrx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Goodrx Holdings's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.05 | |||
| Information Ratio | 0.0291 | |||
| Maximum Drawdown | 13.56 | |||
| Value At Risk | (4.08) | |||
| Potential Upside | 5.16 |
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.